NeuroPace to Highlight Expanding Role of Responsive Neuromodulation at the 2026 American Society for Stereotactic and Functional Neurosurgery Meeting Medical Device Investing
NeuroPace Announces FDA Approval of ECoG Assistant, Advancing AI-Driven Epilepsy Care Medical Device Investing
Pulse Biosciences to Present at the Goldman Sachs 47th Annual Global Healthcare Conference 2026 Medical Device Investing
Delcath Systems Announces Two ASCO 2026 Investigator Initiated Trials-in-Progress Abstracts Life Science Investing
Henry Schein Announces the Election of William K. "Dan" Daniel as Independent Chairman of the Board Life Science Investing
Medtronic announces intent to acquire SPR Therapeutics, Inc., expanding care options for people living with chronic pain Medical Device Investing
Resmed Announces Participation in the 46th Annual William Blair Growth Stock Conference Life Science Investing
